Skip to content

Comparative Study of Rasnasaptak kwatha and Palashadi Niruha Basti with Lashuna-Erandadi Kashaya and Erandmooladi Niruha Basti in Vataja-Yonivyapada (Irregular/Scanty/ Painful menstruation)

Comparision of Rasnasaptak kwatha and Palashadi Niruha Basti with Lashuna-Erandadi Kashaya and Erandmooladi Niruha Basti in Vataja-Yonivyapada.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042182
Enrollment
60
Registered
2022-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified Health Condition 2: N941- Dyspareunia Health Condition 3: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

DEPARTMENT OF PRASUTI TANTRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Reproductive Age Group (16years to 45 years of age) 2. Patient complaining of any 4 criteria which is mention in assessment criteria(Amount of Menstrual Blood loss, Duration of Menstrual bleeding, Interval of Menstrual Cycle, Colour of Menstrual Blood, Dysmenorhhoea, Dyspareunia, Pelvic Pain, Sensory changes in genital organs) for at least 2 consecutive cycles. 3. Patients who are ready for necessary investigations and agreed to come for follow up regularly. 4. Patients who are ready to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant women, women with chronic ailments (systemic diseases like TB, DM, jaundice, bronchial asthma, cardiovascular diseases, renal problems), piles, fistula, fissures or having any history of psychological disorders. 2.Patients having history of any drug allergy. 3.Patients suffering from any disease of external genital tract like any boil, infected cyst Bartholin gland abscess any skin disease like eczema, vulvovaginitis. 4.Perimenopausal Women. 5.Women suffering from Acute P.I.D. 6.Patient not giving consent to participation in the study. 7.Patient who canâ??t attend follow-up regularly.

Design outcomes

Primary

MeasureTime frame
Assessment will be done on the basis of Amount of menstrual blood loss, duration of flow, Interval of menstrual cycle, dysmenorrhea, dyspareunia and pelvic pain.Timepoint: 5 follow-up will be done at every 15 days. Four follow-ups with medication and last follow-up will be done without medication.

Secondary

MeasureTime frame
Changes in the Assessment criteria-Amount of menstrual blood loss, duration of Menstruation and interval, dysmenorrhea, dyspareunia and pelvic painTimepoint: 3 months after completion of treatment

Countries

India

Contacts

Public ContactDR VISHWESH BN

BANARAS HINDU UNIVERSITY

vishweshbn@gmail.com8277033135

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026